z-logo
open-access-imgOpen Access
Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patients
Author(s) -
Barbara SeitzPolski,
Christine Payré,
Damien Ambrosetti,
Laetitia Albano,
E. CassutoViguier,
M. Berguignat,
Ahmed Jeribi,
Marie-Christine Thouret,
Ghislaine Bernard,
Sylvia Benzaken,
Gérard Lambeau,
Vincent Esnault
Publication year - 2014
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfu252
Subject(s) - medicine , autoantibody , membranous nephropathy , transplantation , receptor , phospholipase a2 , kidney transplantation , immunology , gastroenterology , glomerulonephritis , pathology , kidney , antibody , enzyme , biochemistry , biology
The predictive value of anti-M-type phospholipase A2 receptor (PLA2R1) autoantibodies for membranous nephropathy (MN) recurrence after renal transplantation remains controversial.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom